NCT04250402

Brief Summary

Through previous clinical observations and literature, we found that the incidence of gallstones in patients after gastric cancer radical resection was significantly higher than that in the normal population (4%). However, its pathogenesis has not been clarified. We compare the risk of gallbladder stones after four different radical gastric cancer surgical methods, in order to provide prevention and treatment strategies for people with gallstones after gastric cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,019

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 31, 2020

Completed
14 days until next milestone

Study Start

First participant enrolled

February 14, 2020

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2024

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

4.8 years

First QC Date

January 29, 2020

Last Update Submit

November 16, 2024

Conditions

Keywords

GallstonesGastric cancerGastrectomyESDVagus nerve

Outcome Measures

Primary Outcomes (1)

  • Number of gallstone patients

    Four different gastric cancer patients were followed up for more than 1 year. The number of patients with gallbladder stones revealed by B-ultrasound

    3 years

Secondary Outcomes (3)

  • Number of malignant metastasis

    3 years

  • Number of short-term deaths

    3 months

  • Number of physical regurgitation, nausea, vomiting, diarrhea, constipation

    3 years

Study Arms (4)

Arm 1

Endoscopic submucosal dissection. Endoscopic submucosal dissection is an endoscopic procedure which can achieve en bloc resection of GI tumor. ESD is characterized by three steps: injecting fluid into the submucosa to elevate the lesion from the muscle layer, circumferential cutting of the surrounding mucosa of the lesion, and subsequent dissection of the connective tissue of the submucosa beneath the lesion. The ESD procedure will be carried out by experienced endoscopists. Other Name: ESD

Procedure: Resection

Arm 2

Distal subtotal gastrectomy with D2 lymphadenectomy. After exclusion of T4b, bulky lymph nodes, or distant metastasis case, distal subtotal gastrectomy and D2 lymph node dissection will be performed with curative treated intent. The type of reconstruction will be selected according to the surgeon's experience and anastomotic procedure is performed extracorporeally.

Procedure: Resection

Arm 3

Total gastrectomy with D2 lymphadenectomy will be performed with curative treated intent. The type of reconstruction will be with jejunal interposition reconstruction.

Procedure: Resection

Arm 4

Proximal gastrectomy with D2 lymphadenectomy. The type of reconstruction will be jejunal interposition with double anastomosis method.

Procedure: Resection

Interventions

ResectionPROCEDURE

Radical resection.

Arm 1Arm 2Arm 3Arm 4

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Gastric cancer patients

You may qualify if:

  • Gastric cancer patients
  • Age from over 18 to under 75 years

You may not qualify if:

  • Gallbladder disease before surgery
  • Gallbladder has been remove
  • History of previous upper abdominal surgery
  • History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection
  • History of other malignant disease within past five years
  • History of previous neoadjuvant chemotherapy or radiotherapy
  • History of unstable angina or myocardial infarction within past six months
  • History of cerebrovascular accident within past six months
  • Requirement of simultaneous surgery for other disease
  • Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer
  • Pregnant women or breastfeeding
  • Unwillingness or inability to consent for the study
  • Severe mental disorder
  • Unstable vital signs Coagulation dysfunction (INR\>1.5)
  • Low peripheral blood platelet count (\<50Ă—10 \^9 / L) or using anti- coagulation drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hepatopancreatobiliary Surgery Institute of Gansu Province

Lanzhou, Gansu, 730000, China

Location

Wuwei turmour hospital

Wuwei, Gansu, 733000, China

Location

Related Publications (2)

  • Park DJ, Kim KH, Park YS, Ahn SH, Park do J, Kim HH. Risk Factors for Gallstone Formation after Surgery for Gastric Cancer. J Gastric Cancer. 2016 Jun;16(2):98-104. doi: 10.5230/jgc.2016.16.2.98. Epub 2016 Jun 24.

    PMID: 27433395BACKGROUND
  • Furukawa H, Ohashi M, Honda M, Kumagai K, Nunobe S, Sano T, Hiki N. Preservation of the celiac branch of the vagal nerve for pylorus-preserving gastrectomy: is it meaningful? Gastric Cancer. 2018 May;21(3):516-523. doi: 10.1007/s10120-017-0776-8. Epub 2017 Nov 10.

    PMID: 29127549BACKGROUND

MeSH Terms

Conditions

GallstonesStomach Neoplasms

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsGastrointestinal DiseasesStomach Diseases

Study Officials

  • Wenbo Meng, M.D., Ph. D.

    Hepatopancreatobiliary Surgery Institute of Gansu Province

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Direct of surgery

Study Record Dates

First Submitted

January 29, 2020

First Posted

January 31, 2020

Study Start

February 14, 2020

Primary Completion

November 16, 2024

Study Completion

November 16, 2024

Last Updated

November 19, 2024

Record last verified: 2024-11

Locations